UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Thiazolidinediones and fracture risk in patients with Type 2 diabetes

Diabetic medicine, 2011-07, Vol.28 (7), p.759-771

Betteridge, D. J.

2011

Volltextzugriff (PDF)

What is oxidative stress?

Metabolism, clinical and experimental, 2000-02, Vol.49 (2), p.3-8

Betteridge, D. John

2000

Volltextzugriff (PDF)

Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis

Diabetologia, 2010, Vol.53 (7), p.1258-1269

2010

Volltextzugriff (PDF)

Genetic causes of familial hypercholesterolaemia in patients in the UK: relation to plasma lipid levels and coronary heart disease risk

Journal of medical genetics, 2006-12, Vol.43 (12), p.943-949

2006

Volltextzugriff (PDF)

Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes

Diabetologia, 2006-11, Vol.49 (11), p.2756-2762

2006

Volltextzugriff (PDF)

Impact of peripheral arterial disease in patients with diabetes—Results from PROactive (PROactive 11)

Atherosclerosis, 2009-01, Vol.202 (1), p.272-281

2009

Volltextzugriff (PDF)

Effect of insulin on the soluble receptor for advanced glycation end products (RAGE)

Diabetic medicine, 2013-06, Vol.30 (6), p.702-709

2013

Volltextzugriff (PDF)

Long-term effects on lipids and lipoproteins of pioglitazone versus gliclazide addition to metformin and pioglitazone versus metformin addition to sulphonylurea in the treatment of type 2 diabetes

Diabetologia, 2005-12, Vol.48 (12), p.2477-2481

2005

Volltextzugriff (PDF)

Effects of atorvastatin on serum soluble receptors for advanced glycation end-products in type 2 diabetes

Atherosclerosis, 2010-03, Vol.209 (1), p.173-177

2010

Volltextzugriff (PDF)

Thiazolidinedione increases serum soluble receptor for advanced glycation end-products in type 2 diabetes

Diabetologia, 2007-09, Vol.50 (9), p.1819-1825

2007

Volltextzugriff (PDF)

Relationships between plasma measures of oxidative stress and metabolic control in NIDDM

Diabetologia, 1997-06, Vol.40 (6), p.647-653

1997

Volltextzugriff (PDF)

Effects of rosuvastatin on lipids, lipoproteins and apolipoproteins in the dyslipidaemia of diabetes

Diabetic medicine, 2007-05, Vol.24 (5), p.541-549

2007

Volltextzugriff (PDF)

Long-term glycaemic control with metformin-sulphonylurea-pioglitazone triple therapy in PROactive (PROactive 17)

Diabetic medicine, 2009-10, Vol.26 (10), p.1033-1039

2009

Volltextzugriff (PDF)

All-cause and cardiovascular mortality in treated patients with severe hypertriglyceridaemia: A long-term prospective registry study

Atherosclerosis, 2010-08, Vol.211 (2), p.618-623

2010

Volltextzugriff (PDF)

effect of sensitisation to insulin with pioglitazone on fasting and postprandial lipid metabolism, lipoprotein modification by lipases, and lipid transfer activities in type 2 diabetic patients

Diabetologia, 2006-03, Vol.49 (3), p.527-537

2006

Volltextzugriff (PDF)

Rapid emergence of effect of atorvastatin on cardiovascular outcomes in the Collaborative Atorvastatin Diabetes Study (CARDS)

Diabetologia, 2005-12, Vol.48 (12), p.2482-2485

2005

Volltextzugriff (PDF)

Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia

Heart (British Cardiac Society), 2004-12, Vol.90 (12), p.1431-1437

2004

Volltextzugriff (PDF)

Apolipoproteins, cardiovascular risk and statin response in type 2 diabetes: the Collaborative Atorvastatin Diabetes Study (CARDS)

Diabetologia, 2009-02, Vol.52 (2), p.218-225

2009

Volltextzugriff (PDF)

Reflux episodes detected by impedance in patients on and off esomeprazole: a randomised double‐blinded placebo‐controlled crossover study

Alimentary pharmacology & therapeutics, 2013-05, Vol.37 (10), p.1011-1018

2013

Volltextzugriff (PDF)

The effect of atorvastatin on serum lipids, lipoproteins and NMR spectroscopy defined lipoprotein subclasses in type 2 diabetic patients with ischaemic heart disease

Atherosclerosis, 2003-04, Vol.167 (2), p.243-255

2003

Volltextzugriff (PDF)

Design of the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with Type 2 diabetes

Diabetic medicine, 2002-03, Vol.19 (3), p.201-211

2002

Volltextzugriff (PDF)

Comparison of the risk of fatal coronary heart disease in treated xanthomatous and non-xanthomatous heterozygous familial hypercholesterolaemia: a prospective registry study

Atherosclerosis, 2003-09, Vol.170 (1), p.73-78

2003

Volltextzugriff (PDF)

Cost-effectiveness of primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes: results from the Collaborative Atorvastatin Diabetes Study (CARDS)

Diabetologia, 2007-04, Vol.50 (4), p.733-740

2007

Volltextzugriff (PDF)

Non-coronary heart disease mortality and risk of fatal cancer in patients with treated heterozygous familial hypercholesterolaemia: a prospective registry study

Atherosclerosis, 2005-04, Vol.179 (2), p.293-297

2005

Volltextzugriff (PDF)

Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein(a) level

The Journal of clinical investigation, 1994, Vol.93 (1), p.50-55

1994

Volltextzugriff (PDF)

1 – 25 von 576

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(455)
Mit Volltextzugriff
(434)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(301)
Life Sciences & Biomedicine
(270)
Humans
(268)
Female
(162)
Biological And Medical Sciences
(149)
Male
(145)
Medical Sciences
(127)
Middle Aged
(112)
Adult
(110)
Endocrinology & Metabolism
(67)
Risk Factors
(67)
Aged
(66)
General & Internal Medicine
(57)
Medicine, General & Internal
(57)
Endocrinopathies
(53)
Cardiovascular System & Cardiology
(50)
Diabetes
(50)
Diabetes. Impaired Glucose Tolerance
(49)
Endocrine Pancreas. Apud Cells
(49)
Animals
(46)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Canadian Hiv/aids Policy & Law Review
(41)
The Lancet
(27)
Diabetologia
(20)
Atherosclerosis
(19)
Diabetic Medicine
(18)
Bmj
(17)
Bmj. British Medical Journal
(17)
British Medical Journal
(16)
Clinical Science
(16)
European Journal Of Clinical Investigation
(12)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Thiazolidinediones and fracture risk in patients with Type 2 diabetes

What is oxidative stress?

Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis

Genetic causes of familial hypercholesterolaemia in patients in the UK: relation to plasma lipid levels and coronary heart disease risk

Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes

Impact of peripheral arterial disease in patients with diabetes—Results from PROactive (PROactive 11)

Effect of insulin on the soluble receptor for advanced glycation end products (RAGE)

Long-term effects on lipids and lipoproteins of pioglitazone versus gliclazide addition to metformin and pioglitazone versus metformin addition to sulphonylurea in the treatment of type 2 diabetes

Effects of atorvastatin on serum soluble receptors for advanced glycation end-products in type 2 diabetes

Thiazolidinedione increases serum soluble receptor for advanced glycation end-products in type 2 diabetes

Relationships between plasma measures of oxidative stress and metabolic control in NIDDM

Effects of rosuvastatin on lipids, lipoproteins and apolipoproteins in the dyslipidaemia of diabetes

Long-term glycaemic control with metformin-sulphonylurea-pioglitazone triple therapy in PROactive (PROactive 17)

All-cause and cardiovascular mortality in treated patients with severe hypertriglyceridaemia: A long-term prospective registry study

effect of sensitisation to insulin with pioglitazone on fasting and postprandial lipid metabolism, lipoprotein modification by lipases, and lipid transfer activities in type 2 diabetic patients

Rapid emergence of effect of atorvastatin on cardiovascular outcomes in the Collaborative Atorvastatin Diabetes Study (CARDS)

Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia

Apolipoproteins, cardiovascular risk and statin response in type 2 diabetes: the Collaborative Atorvastatin Diabetes Study (CARDS)

Reflux episodes detected by impedance in patients on and off esomeprazole: a randomised double‐blinded placebo‐controlled crossover study

The effect of atorvastatin on serum lipids, lipoproteins and NMR spectroscopy defined lipoprotein subclasses in type 2 diabetic patients with ischaemic heart disease

Design of the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with Type 2 diabetes

Comparison of the risk of fatal coronary heart disease in treated xanthomatous and non-xanthomatous heterozygous familial hypercholesterolaemia: a prospective registry study

Cost-effectiveness of primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes: results from the Collaborative Atorvastatin Diabetes Study (CARDS)

Non-coronary heart disease mortality and risk of fatal cancer in patients with treated heterozygous familial hypercholesterolaemia: a prospective registry study

Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein(a) level

Suchergebnisse filtern